Annovis Bio Investor Relations Material
Latest events
Status Update
Annovis Bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Annovis Bio Inc
Access all reports
Annovis Bio Inc. is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and other central nervous system disorders. The company specializes in small molecule therapies designed to reduce neurotoxic proteins and improve brain function. The company is headquartered in Berwyn, Pennsylvania, and its shares are listed on the NASDAQ.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
ANVS
Country
🇺🇸 United States